FS Investment (FSIC) EPS Estimated At $0.19; Perceptive Advisors Has Upped Exact Sciences (EXAS) Stake By $1.67 Million

February 22, 2018 - By Peter Erickson

Analysts expect FS Investment Corporation (NYSE:FSIC) to report $0.19 EPS on March, 1 after the close.They anticipate $0.04 EPS change or 17.39% from last quarter’s $0.23 EPS. FSIC’s profit would be $46.69 million giving it 9.67 P/E if the $0.19 EPS is correct. After having $0.21 EPS previously, FS Investment Corporation’s analysts see -9.52% EPS growth. It closed at $7.35 lastly. It is down 1.01% since February 22, 2017 and is uptrending. It has underperformed by 15.69% the S&P500.

Perceptive Advisors Llc increased Exact Sciences Corp (EXAS) stake by 35.44% reported in 2017Q3 SEC filing. Perceptive Advisors Llc acquired 35,444 shares as Exact Sciences Corp (EXAS)’s stock rose 53.09%. The Perceptive Advisors Llc holds 135,444 shares with $6.38 million value, up from 100,000 last quarter. Exact Sciences Corp now has $5.58 billion valuation. The stock decreased 2.85% or $1.37 during the last trading session, reaching $46.64. About 2.62M shares traded or 8.54% up from the average. Exact Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since February 22, 2017 and is uptrending. It has outperformed by 441.54% the S&P500.

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.26, from 1.27 in 2017Q2. It dropped, as 39 investors sold EXAS shares while 81 reduced holdings. 44 funds opened positions while 77 raised stakes. 93.65 million shares or 1.18% less from 94.77 million shares in 2017Q2 were reported. Amer Registered Investment Advisor accumulated 14,700 shares or 0.35% of the stock. Adams Diversified Equity Fund holds 0.05% or 19,200 shares. Sva Plumb Wealth Mngmt Limited Liability Com reported 41,893 shares. Hightower Advsrs Ltd Limited Liability Company holds 285,902 shares. Axa invested 0.01% in Exact Sciences Corporation (NASDAQ:EXAS). Lpl Fin Lc accumulated 35,799 shares. Fisher Asset Mgmt Ltd Co holds 0% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS) for 6,350 shares. Hanseatic Incorporated stated it has 0% in Exact Sciences Corporation (NASDAQ:EXAS). Rathbone Brothers Public Limited Com invested in 12,800 shares. 30 were accumulated by Perigon Wealth Mgmt Lc. Parkside Comml Bank & holds 91 shares. Tower Research Limited Liability (Trc) holds 7,196 shares. Los Angeles Cap Mngmt & Equity Rech Inc invested in 19,255 shares. Parametric Associate Limited Liability Corporation accumulated 0.01% or 147,509 shares. Sectoral Asset Inc accumulated 117,550 shares or 0.71% of the stock.

Perceptive Advisors Llc decreased Corbus Pharmaceuticals Hldgs stake by 817,816 shares to 414,684 valued at $2.96 million in 2017Q3. It also reduced Blueprint Medicines Corp stake by 20,000 shares and now owns 424,661 shares. Galapagos N V was reduced too.

Since September 1, 2017, it had 0 insider purchases, and 8 insider sales for $27.11 million activity. Conroy Kevin T sold $6.62M worth of Exact Sciences Corporation (NASDAQ:EXAS) on Friday, January 12. Shares for $1.37M were sold by COWARD D SCOTT on Friday, September 29. Shares for $3.09M were sold by LIDGARD GRAHAM PETER on Tuesday, September 5.

Among 18 analysts covering EXACT Sciences (NASDAQ:EXAS), 10 have Buy rating, 1 Sell and 7 Hold. Therefore 56% are positive. EXACT Sciences had 65 analyst reports since July 24, 2015 according to SRatingsIntel. Goldman Sachs maintained Exact Sciences Corporation (NASDAQ:EXAS) on Tuesday, October 6 with “Neutral” rating. Benchmark maintained the stock with “Buy” rating in Tuesday, October 31 report. The stock has “Buy” rating by Jefferies on Thursday, February 25. On Thursday, August 24 the stock rating was maintained by Leerink Swann with “Buy”. The company was downgraded on Wednesday, November 1 by BTIG Research. The firm earned “Hold” rating on Wednesday, October 7 by Lake Street. Bank of America maintained Exact Sciences Corporation (NASDAQ:EXAS) on Tuesday, October 31 with “Buy” rating. The company was initiated on Thursday, October 1 by Craig Hallum. The stock has “Buy” rating by Leerink Swann on Monday, November 13. The stock of Exact Sciences Corporation (NASDAQ:EXAS) earned “Buy” rating by Benchmark on Wednesday, January 17.

FS Investment Corporation is a business development firm specializing in investments in debt securities. The company has market cap of $1.81 billion. It seeks to purchase interests in loans through secondary market transactions or directly from the target companies as primary market investments. It has a 8.21 P/E ratio. It also seeks to invest in first lien senior secured loans, second lien secured loans and, to a lesser extent, subordinated loans, or mezzanine loans.

Among 10 analysts covering FS Investment (NYSE:FSIC), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 30% are positive. FS Investment had 16 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of FS Investment Corporation (NYSE:FSIC) earned “Hold” rating by Keefe Bruyette & Woods on Thursday, November 9. On Sunday, July 23 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. On Wednesday, September 30 the stock rating was initiated by DA Davidson with “Buy”. Wood maintained the shares of FSIC in report on Monday, May 1 with “Hold” rating. On Monday, January 11 the stock rating was upgraded by Cantor Fitzgerald to “Buy”. The stock has “Market Perform” rating by Wells Fargo on Friday, March 3. The stock of FS Investment Corporation (NYSE:FSIC) has “Neutral” rating given on Friday, December 18 by Sterne Agee CRT. The firm has “Neutral” rating by JP Morgan given on Thursday, August 11. On Wednesday, May 31 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Barclays Capital downgraded FS Investment Corporation (NYSE:FSIC) rating on Wednesday, September 7. Barclays Capital has “Equal-Weight” rating and $9 target.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: